Intercept Pharmaceuticals, Inc.: accounts_receivable
| Value | {"amount": 16944000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2018-03-31) |
| Status | current |
| Entity | Intercept Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:06:47.985899+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/af5ba1db-45f4-4ee4-b6da-2a2faa0e83ac
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-18-027184 · Open the official SEC filing →Retrieved: 2026-08-19T12:06:47.985899+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001270073/accounts-receivable/2018-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/af5ba1db-45f4-4ee4-b6da-2a2faa0e83ac
History
- no predecessors — first report